| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/01/2000 | CA2173387C A process for the preparation of a liposomal, in water dispersive, orally administerable, solid, dry therapeutic formulation |
| 02/01/2000 | CA2163348C Calanolide and related antiviral compounds, compositions, and uses thereof |
| 02/01/2000 | CA2161703C Pour-on formulations containing polymeric material, glycols and glycerides |
| 02/01/2000 | CA2144947C Serotonin receptor agents |
| 02/01/2000 | CA2124012C Sustained release diltiazem formulation |
| 02/01/2000 | CA2109575C Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 02/01/2000 | CA2093798C Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof |
| 02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
| 01/30/2000 | CA2244535A1 Novel uses for ascorbyl-phosphoryl-cholesterol in topical compositions |
| 01/27/2000 | WO2000004187A2 Methods and kits for diagnosing and determination of the predisposition of diseases |
| 01/27/2000 | WO2000004157A2 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | WO2000004141A2 Use of nucleic acid molecules as antiviral agents |
| 01/27/2000 | WO2000004086A1 Polyionic hydrogels based on xanthan and chitosan for stabilising and controlled release of vitamins |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004034A2 Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages |
| 01/27/2000 | WO2000004033A1 Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino] -1-benzyl-2- (phosphonooxy) propylcarbamate |
| 01/27/2000 | WO2000004031A1 Phosphorous organic compounds and their use |
| 01/27/2000 | WO2000004030A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 01/27/2000 | WO2000004027A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/27/2000 | WO2000004024A1 Antiparasitic artemisinin derivatives (endoperoxides) |
| 01/27/2000 | WO2000004023A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 01/27/2000 | WO2000004022A1 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas |
| 01/27/2000 | WO2000004021A1 NOVEL TRIAZOLO[4,5-d]PYRIMIDINE COMPOUNDS |
| 01/27/2000 | WO2000004020A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 01/27/2000 | WO2000004019A1 5-bicycloindole compounds |
| 01/27/2000 | WO2000004018A1 Ergoline amine derivatives with blood pressure lowering effect |
| 01/27/2000 | WO2000004016A2 Polymorph of ritonavir |
| 01/27/2000 | WO2000004013A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | WO2000004012A1 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF |
| 01/27/2000 | WO2000004011A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 01/27/2000 | WO2000004010A1 Bicyclohexane derivatives |
| 01/27/2000 | WO2000004006A1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments |
| 01/27/2000 | WO2000004002A1 Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them |
| 01/27/2000 | WO2000004001A1 Substituted piperazones and their therapeutic uses |
| 01/27/2000 | WO2000004000A1 Piperazinone derivatives and their uses |
| 01/27/2000 | WO2000003997A1 Thiobenzimidazole derivatives |
| 01/27/2000 | WO2000003996A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 01/27/2000 | WO2000003994A2 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
| 01/27/2000 | WO2000003992A1 Quinoline derivatives |
| 01/27/2000 | WO2000003991A1 Quinoline derivatives |
| 01/27/2000 | WO2000003990A1 Pharmaceutical compositions comprising 2-quinolones |
| 01/27/2000 | WO2000003986A1 Bispiperidines as antithrombotic agents |
| 01/27/2000 | WO2000003981A2 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 01/27/2000 | WO2000003980A1 5-THIA-φ-SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 01/27/2000 | WO2000003979A1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments |
| 01/27/2000 | WO2000003978A2 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 01/27/2000 | WO2000003977A1 Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
| 01/27/2000 | WO2000003973A1 Diacylhydrazine derivatives as integrin inhibitors |
| 01/27/2000 | WO2000003749A2 Method for regulating hair growth |
| 01/27/2000 | WO2000003748A2 Compositions which contain triterpenes for regulating hair growth |
| 01/27/2000 | WO2000003746A2 Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization |
| 01/27/2000 | WO2000003745A2 Polysaccharide vaccine for staphylococcal infections |
| 01/27/2000 | WO2000003742A2 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 01/27/2000 | WO2000003741A2 Methods for reducing intraocular pressure using a3-adenosine antagonists |
| 01/27/2000 | WO2000003740A2 Use of (s) (-)-amisulpride for the manufacture of a medicament for the treatment of schizophrenia |
| 01/27/2000 | WO2000003737A2 Water-soluble drugs and methods for their production |
| 01/27/2000 | WO2000003734A1 Therapeutic agents for allergic diseases |
| 01/27/2000 | WO2000003723A1 Polymeric compounds and methods of formulating same |
| 01/27/2000 | WO2000003722A1 Nocathiacin antibiotics |
| 01/27/2000 | WO2000003721A1 Immunosupportive drug sparing diet |
| 01/27/2000 | WO2000003719A1 Utilization of estrogens for producing a locally applicable preparation for preventing and treating atrophic symptoms in the oral cavity |
| 01/27/2000 | WO2000003718A1 Freeze-dried preparations and process for producing the same |
| 01/27/2000 | WO2000003717A1 Method of treatment |
| 01/27/2000 | WO2000003716A1 Topical compositions comprising an opioid analgesic and an nmda antagonist |
| 01/27/2000 | WO2000003715A1 Treatment of dyskinesia |
| 01/27/2000 | WO2000003714A1 Medicinal product and method for treatment and prevention of dyskinesia |
| 01/27/2000 | WO2000003713A1 Treatment for schizophrenia and other dopamine system dysfunctions |
| 01/27/2000 | WO2000003711A1 Compounds and compositions for treating tissue ischemia |
| 01/27/2000 | WO2000003710A1 Oxazolidinones to treat eye infections |
| 01/27/2000 | WO2000003709A1 Novel dna-cleaving antitumor agents |
| 01/27/2000 | WO2000003708A1 Analgesic use of podophyllotoxin for treating pain conditions in female genital organs |
| 01/27/2000 | WO2000003707A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 01/27/2000 | WO2000003706A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 01/27/2000 | WO2000003705A1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 01/27/2000 | WO2000003704A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | WO2000003703A1 Novel remedies for allergic diseases |
| 01/27/2000 | WO2000003702A1 New pharmaceutical preparation and method |
| 01/27/2000 | WO2000003701A1 Composition for treatment of stress |
| 01/27/2000 | WO2000003700A1 Compositions and methods of treating abnormal cell proliferation |
| 01/27/2000 | WO2000003698A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 01/27/2000 | WO2000003697A1 Pellets having a core coated with an antifungal and a polymer |
| 01/27/2000 | WO2000003696A1 Enteric coated pharmaceutical tablet and method of manufacturing |
| 01/27/2000 | WO2000003695A1 Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose |
| 01/27/2000 | WO2000003691A1 Systems and methods for local delivery of an agent |
| 01/27/2000 | WO2000003689A2 Skin and tissue care and/or treatment agent |
| 01/27/2000 | WO2000003684A2 Soy formulations and their use for promoting health |
| 01/27/2000 | WO2000003683A2 Liposomal encapsulated nucleic acid-complexes |
| 01/27/2000 | WO2000003682A2 Chemical composition having spermicidal, bactericidal and virucidal activity and apparatus for delivery into the vaginal canal |
| 01/27/2000 | WO2000003680A2 Emollient esters based upon capryl alcohol and isostearic acid |
| 01/27/2000 | WO2000003678A2 Subcutaneous medroxyprogesterone acetate for contraception |
| 01/27/2000 | WO2000003677A2 Use of bisphosphonates in the treatment of vascular restenosis |
| 01/27/2000 | WO2000003660A1 Biodegradable compositions for the controlled release of encapsulated substances |
| 01/27/2000 | WO1999065451A3 Caspases and apoptosis |
| 01/27/2000 | WO1999064416A3 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/27/2000 | WO1999063938A3 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999063115A3 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 01/27/2000 | WO1999062503A3 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
| 01/27/2000 | WO1999061406A3 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 01/27/2000 | WO1999061059A8 Minoxidil compositions for external use |